Employees: 11 (2023.0)Legal category: 5485Size: PMECreation date: 2022-05-03 (3 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: BOURGES (18000), Cher
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
SELARL PHARMACIE CENTRALE : revenue, balance sheet and financial ratios
SELARL PHARMACIE CENTRALE is a French company
founded 3 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in BOURGES (18000),
this company of category PME
shows in 2023 a net income negative of -252 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SELARL PHARMACIE CENTRALE (SIREN 913155586)
Indicator
2023
2022
Revenue
N/C
N/C
Net income
-252 288 €
-19 959 €
EBITDA
N/C
N/C
Net margin
N/C
N/C
Revenue and income statement
In 2023, SELARL PHARMACIE CENTRALE records a net loss of 252 k€. This deficit will reduce equity on the balance sheet.
Net income (2023)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
-252 288 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at -1118%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches -8%. Low autonomy: the company heavily depends on external financing (banks, suppliers).
Debt ratio (2023)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
-1117.799%
Financial autonomy (2023)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
-8.351%
Asset age ratio (2023)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution SELARL PHARMACIE CENTRALE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2022
2023
Debt ratio
3585.974
-1117.799
Financial autonomy
2.152
-8.351
Repayment capacity
None
None
Cash flow / Revenue
None%
None%
Sector positioning
Debt ratio
-1117.82023
2022
2023
Q1: 20.09
Med: 66.92
Q3: 169.24
Excellent-50 pts over 2 years
In 2023, the debt ratio of SELARL PHARMACIE CENTRALE (-1117.80) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
Financial autonomy
-8.35%2023
2022
2023
Q1: 28.72%
Med: 48.51%
Q3: 68.17%
Average
In 2023, the financial autonomy of SELARL PHARMACIE CENTRALE (-8.3%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 104.06. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2023)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
104.062
Liquidity indicators evolution SELARL PHARMACIE CENTRALE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2022
2023
Liquidity ratio
132.057
104.062
Interest coverage
None
None
Sector positioning
Liquidity ratio
104.062023
2022
2023
Q1: 135.23
Med: 189.76
Q3: 270.17
Watch
In 2023, the liquidity ratio of SELARL PHARMACIE CENTRALE (104.06) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
Positioning of SELARL PHARMACIE CENTRALE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELARL PHARMACIE CENTRALE with other companies in the same sector:
Frequently asked questions about SELARL PHARMACIE CENTRALE
What is the revenue of SELARL PHARMACIE CENTRALE ?
The revenue of SELARL PHARMACIE CENTRALE is not publicly disclosed (confidential accounts filed with INPI).
Is SELARL PHARMACIE CENTRALE profitable?
SELARL PHARMACIE CENTRALE recorded a net loss in 2023.
Where is the headquarters of SELARL PHARMACIE CENTRALE ?
The headquarters of SELARL PHARMACIE CENTRALE is located in BOURGES (18000), in the department Cher.
Where to find the tax return of SELARL PHARMACIE CENTRALE ?
The tax return of SELARL PHARMACIE CENTRALE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELARL PHARMACIE CENTRALE operate?
SELARL PHARMACIE CENTRALE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart